Does MEGLUMINE Cause Muscular weakness? 165 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Muscular weakness have been filed in association with MEGLUMINE. This represents 28.2% of all adverse event reports for MEGLUMINE.
165
Reports of Muscular weakness with MEGLUMINE
28.2%
of all MEGLUMINE reports
164
Deaths
162
Hospitalizations
How Dangerous Is Muscular weakness From MEGLUMINE?
Of the 165 reports, 164 (99.4%) resulted in death, 162 (98.2%) required hospitalization, and 162 (98.2%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which MEGLUMINE Alternatives Have Lower Muscular weakness Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE